PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity
========================================================================================================================================

* Emmanuelle Moraes Ribeiro
* Kathy-Ann Secker
* Ana-Maria Nitulescu
* Rebekka Schairer
* Hildegard Keppeler
* Anton Wesle
* Hannes Schmid
* Anita Schmitt
* Brigitte Neuber
* Daniela Chmiest
* Silvia Podavini
* Melanie Märklin
* Boris Klimovich
* Michael Schmitt
* Fulya Korkmaz
* Claudia Lengerke
* Corina Schneidawind
* Dominik Schneidawind